Novartis has partnered with TheNewsMarket to provide broadcast-standard video - delivered digitally.
To make sure that our assets are available to appropriate audiences, some assets appear locked.
These are password protected and can only be accessed by journalists and a select group of users.
If you are new to the site, please register. Your information will be verified by our team as quickly as possible.
Once approved, you will be sent an email confirming your username and password.
If you are an existing user of TheNewsMarket, please contact the Novartis media team
You may use non-protected material provided in this section for your personal use or for purposes such as news reporting, teaching, scholarship or research.
The assets may not be modified and must display a copyright notice in the name of Novartis (Copyright © Novartis).
The information on these pages was factually accurate on the date of publication.
This information remains on Novartis website for historical purposes only.
Novartis assumes no duty to update the information to reflect subsequent developments.
Readers should not rely upon the information in these pages as current or accurate after their publication dates